The myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangements are a provisional entity according to 2016 WHO classification, defined as a heterogeneous neoplasm, consequence of multiple translocations with a breaking point 8p11. This evidence concerns the gene FGFR1 and Increased total eosinophil count.